Drugs / H5N1 (Pre-)Pandemic Influenza Vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT01382329 | Jun → Aug 2011 | avian influenza | Alachua Government Services, Inc. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01911754 | Aug → Nov 2013 | influenza | Alachua Government Services, Inc. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H5N1 (pre-)pandemic influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01382329 ↗ |
| Modality | Vaccine | “H5N1 pandemic influenza vaccine” NCT01382329 ↗ |
| Route | Intramuscular | “Intramuscular injection into the musculus deltoideus or subcutaneous injection in the upper arm” NCT01382329 ↗ |
| Route | Subcutaneous | “Intramuscular injection into the musculus deltoideus or subcutaneous injection in the upper arm” NCT01382329 ↗ |